A Study to Assess the Efficacy and Tolerance of HRS-2261 in Subjects With Refractory Chronic Cough

NCT05733533 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory Chronic Cough

Interventions

DRUG: HRS-2261 oral tablet
DRUG: Matching placebo to HRS-2261

Sponsor

Guangdong Hengrui Pharmaceutical Co., Ltd